Group 1 - On September 25, Jiahe Meikang's stock rose by 3.20%, with a trading volume of 93.32 million yuan [1] - The financing buy-in amount for Jiahe Meikang on that day was 22.23 million yuan, while the financing repayment was 11.74 million yuan, resulting in a net financing buy-in of 10.50 million yuan [1] - As of September 25, the total balance of margin trading for Jiahe Meikang was 193 million yuan, accounting for 4.73% of its market capitalization [1] Group 2 - As of June 30, the number of shareholders for Jiahe Meikang was 6,655, an increase of 12.93% compared to the previous period [2] - For the first half of 2025, Jiahe Meikang reported operating revenue of 219 million yuan, a year-on-year decrease of 27.22% [2] - The net profit attributable to the parent company for the same period was -116 million yuan, representing a year-on-year decrease of 323.29% [2] Group 3 - The main business of Jiahe Meikang includes medical information software development and industrialization, with revenue composition as follows: software development and technical services 42.39%, self-developed software sales 37.64%, purchased software and hardware sales 19.86%, and other service sales 0.11% [1]

Core Points - The company held its fourth extraordinary general meeting of shareholders on September 15, 2025, with all resolutions passed without any objections [2][4]. - The meeting was chaired by the company's chairman, Xia Jun, and utilized a combination of on-site and online voting methods, complying with legal and company regulations [2][4]. - All seven current directors attended the meeting, along with the board secretary and some senior executives [3]. Voting and Resolutions - Two main resolutions were discussed: the transfer of subsidiary equity and the change of independent directors, both of which were approved [4][5]. - The voting process included separate counting for minority investors, and certain individuals recused themselves from voting on the first resolution [5]. - Both resolutions were passed with more than half of the voting rights represented at the meeting [5]. Legal Verification - The meeting was witnessed by lawyers from Zhonglun Law Firm, who confirmed that all procedures and results were in accordance with legal and regulatory requirements [6].

证券代码：688246 证券简称：嘉和美康 公告编号：2025-063 嘉和美康（北京）科技股份有限公司 2025年第四次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 09 月 15 日 （二） 股东会召开的地点：北京市海淀区东北旺西路 8 号院 28 号楼 1 层会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 54 | | --- | --- | | 普通股股东人数 | 54 | | 2、出席会议的股东所持有的表决权数量 | 47,319,392 | | 普通股股东所持有表决权数量 | 47,319,392 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 34.3926 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 34.3926 ...

北京市中伦律师事务所 关于嘉和美康（北京）科技股份有限公司 2025 年第四次临时股东会的 法律意见书 二〇二五年九月 北京市中伦律师事务所 关于嘉和美康（北京）科技股份有限公司 2025 年第四次临时股东会的 法律意见书 致：嘉和美康（北京）科技股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）、中国证券监督管理委员会发布的《上 市公司股东会规则》（以下简称"《股东会规则》"）的规定，北京市中伦律师 事务所（以下简称"本所"）接受嘉和美康（北京）科技股份有限公司（以下简 称"公司"）的委托，指派本所律师出席公司 2025 年第四次临时股东会（以下 简称"本次股东会"），对本次股东会的相关事项进行见证并出具法律意见。 为出具本法律意见书，本所律师审查了公司提供的相关文件，该等文件包括 但不限于： 1.现行有效的公司章程； 2.于 2025 年 8 月 28 日发布在上海证券交易所网站（www.sse.com.cn）上的 公司关于召开 2025 年第四次临时股东会的通知的公告； 3.公司本次股东会股权登记日（2025 年 9 月 10 日） ...

Core Viewpoint - The announcement from Jiahe Meikang (688246.SH) reveals that shareholder Saifu Puxin plans to reduce its stake in the company due to liquidity needs, intending to sell up to 2,672,492 shares, representing 1.94% of the total share capital [1][2]. Shareholder Reduction Plan - Saifu Puxin intends to sell shares through centralized bidding within 90 days after the announcement, starting from three trading days post-disclosure [1]. - The planned cash-out from this reduction is approximately 79.91 million yuan, based on the closing price of 29.90 yuan per share on September 10 [2]. Shareholding Details - As of the announcement date, Saifu Puxin holds 2,672,492 shares, which is 1.94% of the total shares, acquired prior to the company's IPO [2]. - Saifu Puxin has previously reduced its holdings, selling 2,063,776 shares between April 3 and June 27, 2025, at prices ranging from 26.19 yuan to 33.85 yuan per share [3][4]. Historical Reduction Summary - Since March 13, 2023, Saifu Puxin has cumulatively reduced its holdings by 593,960 shares, realizing approximately 199.20 million yuan in cash [4][5]. - The initial shareholding was 8,612,100 shares, accounting for 6.25% of the total share capital [4]. Company IPO and Fundraising - Jiahe Meikang went public on December 14, 2021, with an issue price of 39.50 yuan per share, raising a total of 1.362 billion yuan, netting 1.240 billion yuan after expenses [6]. - The funds raised are allocated for various projects, including electronic medical record development and operational capital [6].

Core Viewpoint - The announcement from Jiahe Meikang (688246.SH) reveals that shareholder Saifu Puxin plans to reduce its stake in the company due to liquidity needs, intending to sell up to 2,672,492 shares, representing 1.94% of the total share capital, within 90 days from the announcement date [1][2]. Shareholder Reduction Plan - Saifu Puxin holds 2,672,492 shares, accounting for 1.94% of the total shares, which were acquired before the company's initial public offering and have been tradable since December 14, 2022 [2]. - The planned reduction is expected to generate approximately 79.91 million yuan based on the closing price of 29.90 yuan per share on September 10, 2025 [1]. - Saifu Puxin has previously reduced its holdings by 2,063,776 shares between April 3, 2025, and June 27, 2025, at prices ranging from 26.19 yuan to 33.85 yuan per share [2][3]. Historical Shareholding and Reduction - Initially, Saifu Puxin held 8,612,100 shares, which was 6.25% of the total share capital. Since March 13, 2023, it has cumulatively reduced its holdings by 5,939,600 shares, realizing approximately 199 million yuan [3][4]. - The cumulative reduction includes various periods with average selling prices and amounts, with the most recent reduction yielding an average price of 29.8 yuan per share [4]. Company Financials - Jiahe Meikang raised a total of 1.362 billion yuan from its initial public offering, with a net amount of 1.24 billion yuan after deducting issuance costs, exceeding the original plan by 490 million yuan [5]. - The funds raised are allocated for several projects, including the development of specialized electronic medical records and upgrades to data centers [5].

Core Viewpoint - The announcement details a share reduction plan by a major shareholder of Jiahe Meikang (Beijing) Technology Co., Ltd., due to liquidity needs, involving the potential sale of up to 2,672,492 shares, representing 1.94% of the company's total shares [2][3]. Shareholder Holding Situation - As of the announcement date, the shareholder Suzhou Saifu Puxin Medical Health Industry Investment Center (Limited Partnership) holds 2,672,492 shares, accounting for 1.94% of the total shares of Jiahe Meikang [2]. Reduction Plan Details - The shareholder plans to reduce their holdings through centralized bidding, with a maximum of 2,672,492 shares to be sold within 90 days after the announcement, starting from the third trading day [3]. - The reduction will be subject to market conditions, and the selling price will be determined based on market prices. Adjustments will be made if there are any corporate actions affecting share value during the reduction period [3]. Basic Information of the Reducing Entity - The reducing entity does not have any concerted actions with other parties [4]. Past Share Reduction Activities - The announcement does not indicate any prior share reduction activities by the shareholder within the last 12 months [5]. Compliance with Regulations - The reduction plan complies with relevant regulations, including the special provisions for venture capital fund shareholders and the Shanghai Stock Exchange's guidelines [3][10].

Group 1 - Tianpu Co., Ltd. experienced a significant stock price increase of 185.29% from August 22 to September 10, leading to a halt for further investigation due to abnormal trading [4] - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Qingshan Paper Industry confirmed that its production and operational activities are normal, with no significant changes in daily operations [6] Group 2 - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer by its controlling shareholder [7] - ST Jinke will implement a capital reserve transfer to increase share capital, resulting in a one-day stock suspension [8] - ST Haofeng's stock will resume trading on September 11 after a share transfer agreement was signed, making Zhixin Network the controlling shareholder [9] Group 3 - Fushun Special Steel's stock will be suspended for one day due to a tender offer for shares by Ningbo Meishan Free Trade Port Zone Jincheng Shazhou Equity Investment Co., Ltd. [10] - Fuliwang's subsidiary plans to invest 500 million yuan in a high-end wire material research and production project [11] - ST Tianmao's application for voluntary delisting has been accepted by the Shenzhen Stock Exchange [12] Group 4 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of Qinhuai Data China [13] - Betta Pharmaceuticals intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Longzi Co., Ltd. plans to acquire a 67.5% stake in Chongqing Time for approximately 92.475 million yuan [15] Group 5 - Dongfang Guoxin plans to establish a joint venture for a technology company with Shunyi Jin Kong [16] - ST Lianshi signed a pre-restructuring investment agreement with selected investors [18] - Shaanxi Construction Group won four construction projects worth over 5 billion yuan in August [19] Group 6 - Dema Technology won a smart logistics project with a well-known Latin American e-commerce giant, valued at approximately 290 million yuan [20] - Mongolian Grass Ecology's subsidiary led a consortium to win a 225 million yuan ecological restoration project [21] - Dajin Heavy Industry signed a long-term production agreement for offshore wind power foundations, with a total value of about 1.25 billion yuan [24] Group 7 - Zhendong Medical's controlling shareholder plans to transfer 5% of the company's shares [25] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [26] - BYD's senior management and core personnel collectively increased their holdings by approximately 52.33 million yuan [27] Group 8 - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% [28] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% [30] - Lanke Technology's shareholders plan to reduce their holdings by up to 2% [31]

Group 1 - Hualing Steel's shareholder, Xintai Life, has recently increased its stake by 69.0862 million shares and plans to continue increasing its holdings by 1% to 2% [1] - Jingfang Technology's shareholder has terminated its share reduction plan ahead of schedule, with no shares sold during the period [1] - Huali Co., Ltd. plans to reduce its holdings by no more than 3.96% of the company's shares [1] Group 2 - Various companies, including Wuchan Jinlun, Changhua Chemical, COFCO Technology, and Jieshun Technology, have announced plans to reduce their holdings by no more than 3% of their shares [1] - Other companies such as Micron Biotech, Hongbai New Materials, and Jucheng Technology have also indicated plans to reduce their stakes by varying percentages, mostly around 2% to 3% [1] - Specific reductions include 2.61% by Jucheng Co., 2.5% by Zhongju Xinxin, and 1.94% by Jiahe Meikang [1]

Regulatory Actions - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [3] - ST Haofeng announced that Zhixin Network will become the controlling shareholder after a share transfer agreement, with shares resuming trading on September 11, 2025 [7] - Fushun Special Steel will suspend trading for one day due to a share buyback offer, with a total of 9.865 million shares being offered at a price of 5.6 yuan per share [8] Operational Updates - Qingshan Paper Industry reported that its production and operational activities are normal, with no significant changes in daily operations [4] - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer, with an expected suspension period of no more than three trading days [5] - ST Jinke will implement a capital reserve transfer to increase share capital, leading to a one-day trading suspension [6] Major Contracts and Projects - Shaanxi Construction Group won four construction projects each exceeding 500 million yuan in August, including a 2.4 billion yuan project for a solar hydrogen production facility [11] - Demar Technology secured a 2.9 billion yuan contract for an intelligent logistics project with a well-known e-commerce giant in Latin America [13] - Mongolian Grass Ecology's subsidiary led a consortium that won a 2.25 billion yuan project for ecological protection and restoration in Inner Mongolia [14] - Sanfeng Environment signed a contract worth approximately 2.6 billion Macanese Patacas for waste management services in Macau, with a contract duration of 10 years [15] Shareholding Changes - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% through market transactions [17] - Sichuan Road and Bridge's controlling shareholder intends to reduce its stake by up to 2% through block trades [18] - Hexing Co., Ltd. announced that its controlling shareholder plans to reduce its stake by up to 3% through various trading methods [19] - Jingfang Technology's shareholder terminated its share reduction plan without executing any sales during the period [20]